Latest PLK1 Stories
The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen).
A seemingly obscure gene in the female fruit fly that is only active in cells that will become eggs has led researchers at the Stowers Institute for Medical Research to the discovery of a atypical protein that lures, traps, and inactivates the powerful Polo kinase, widely considered the master regulator of cell division.
The American Cancer Society estimates that 44,000 new cases of pancreatic cancer will be diagnosed this year and that 37,000 people will die from the disease.
Purdue University scientists believe they have found an effective target for killing late-stage, metastatic prostate cancer cells.
Only one in twenty cancer drugs makes its way from the laboratory to become an approved pharmaceutical product.
Clinical study open at Virginia G. Piper Cancer Center at Scottsdale Healthcare SCOTTSDALE, Ariz., Jan. 12, 2011 /PRNewswire-USNewswire/ -- A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers.
NMS-1286937 is designed to halt cancer cells from dividing.
A Purdue University scientist has discovered a key process in cell growth that can lead to the formation of tumors. Xiaoqi Liu, an assistant professor of biochemistry.